top of page
Home
Purpose
People
Pipeline
Press
Contact
Praetego
Dec 14, 2023
PROGRAM UPDATES
Praetego’s PTG-630 Successfully Completes a Pre-IND Meeting with the FDA’s Division of Neurology
Praetego successfully completed a Pre-IND meeting with the FDA’s Division of Neurology for PTG-630
Press + Announcements
Praetego’s progress is routinely updated as we strive to enter clinical trials. Please check back frequently for news, announcements, and events.
Home
Purpose
People
Pipeline
Press
Contact
bottom of page